ANTAGONISTIC IN RESPECT TO PROGESTERONE AND ANTIESTROGENICALLY ACTIVE COMPOUNDS FOR COMBINED USE IN FEMALE CONCETRACEPTION

摘要

This invention describes the use of at least one compound with a progesterone-antagonistic (PA) action and at least one compound with an antiestrogenic (AE) action, each in a non-ovulation-inhibiting dosage in a single dosage unit, for the production of pharmaceutical agents for female contraception.